BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, March 17, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Aug. 14, 2025

Aug. 14, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Abbvie, Apertura, Emugen, Fate, Galibra, Generation Bio, Lixte, NextRNA, Oric, Santhera.
Read More

Other news to note for August 13, 2025

Aug. 13, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Dexcom, HFWL, Myra, SC Johnson, Sentientlight.
Read More

Other news to note for Aug. 13, 2025

Aug. 13, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: ADC, Amphastar, Anji, Bridgebio, Handa, Kancera, Nanopalm, Rakovina, Recardio, Xspray.
Read More

Other news to note for August 12, 2025

Aug. 12, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Ainnova Tech, Aquedeon Medical, Caro Health, Clarimed, Fortrea, Healthcare Outcomes Performance, Ocular Therapeutix, Nanopalm, Rakovina, Renata, We Are Human.
Read More

Other news to note for Aug. 12, 2025

Aug. 12, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Eli Lilly, Humacyte, Sitryx, Turnstone, Xoma.
Read More

Other news to note for August 12, 2025

Aug. 12, 2025
Biopharma happenings in Asia-Pacific including deals and partnerships, grants, preclinical data and other news in brief: Astria, Coherus, Fresenius, Intas, Kaken, Kashiv, MS Pharma, Nxera, Neuren, Polpharma, Takea.
Read More

Other news to note for August 11, 2025

Aug. 11, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 10x Genomics, Cardio Partners, Codex Genetics, Hashkey, IVD Medical, Pacific Edge, Real Heart, Rescuestat, Scale Biosciences.
Read More

Other news to note for Aug. 11, 2025

Aug. 11, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Annexon, Bicycle, Biontech, Curevac, GSK, Neuren, Pfizer.
Read More

Other news to note for August 8, 2025

Aug. 8, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: BDC Laboratories, Dialcare, Exact Sciences, Freenome, GE Healthcare, Gentuity, Helix, Nanovibronix, Orchestra Biomed, Reshape Lifesciences, Veracyte, Vyome, Zelis.
Read More

Other news to note for Aug. 8, 2025

Aug. 8, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Absci, Almirall, Coherus, Cormedix, Intas, Keros, Melinta, Novo Nordisk, Prothena.
Read More
Previous 1 2 … 27 28 29 30 31 32 33 34 35 … 1392 1393 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 16, 2026.
  • Art concept for targeting the brain

    Precision psychiatry beyond, or before, biomarkers

    BioWorld
    There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • First-in-class POLG activator restores mtDNA across mutations

    BioWorld Science
    Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing